Vascular Therapies IPO

vasculartx.com

Vascular Therapies is a late-stage biopharmaceutical company focused on developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.

Founded2001
Total Funding to Date$74.51MM
Register for Details

For more details on financing and valuation for Vascular Therapies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Vascular Therapies Ticker Symbol

Vascular Therapies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Vascular Therapies Stock Price

The stock price for Vascular Therapies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Vascular Therapies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM